Valuation: Abbott Laboratories

Market Cap 175B 154B 143B 132B 247B 16,995B 252B 1,715B 669B 8,289B 659B 645B 28,758B P/E 2026 *
28.6x
P/E 2027 * 22.2x
Enterprise Value 199B 175B 162B 149B 280B 19,259B 285B 1,943B 758B 9,394B 747B 730B 32,589B EV / Sales 2026 *
3.95x
EV / Sales 2027 * 3.5x
Free-Float
86.73%
Yield 2026 *
2.57%
Yield 2027 * 2.7%
1 day+0.39%
1 week+1.94%
Current month+11.03%
1 month+11.29%
3 months+8.94%
6 months-6.21%
Current year-19.59%
1 week 99.34
Extreme 99.34
102.46
1 month 87.64
Extreme 87.64
102.46
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 30/03/2020
Director of Finance/CFO 53 31/08/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 08/12/2011
Director/Board Member 67 08/12/2011
Director/Board Member 71 15/02/2017
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

363 0.0000%
30/06/26 Tax

EXECUTIVE VICE PRESIDENT

-269 0.0000%
30/06/26 Free

Director

416 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.18%+1.94%-19.93%-11.85% 175B
+0.15%-1.85%-10.87%-7.81% 105B
+1.49%-0.95%+3.96%+58.40% 58.48B
-1.19%-2.66%+26.29%+54.66% 51.36B
-0.12%-4.35%-16.22%-42.24% 42.2B
+1.21%-8.47% - - 31.44B
-1.33%-9.62%-18.45%-46.03% 27.56B
-0.82%-1.92%+56.39%-5.79% 25.32B
+0.03%-4.74%-6.58%-9.24% 20.52B
-0.14%-4.94%-16.95%-3.21% 19.89B
Average -0.03%-2.61%-0.26%-1.46% 55.68B
Weighted average by Cap. +0.15%-1.13%-6.26%-0.23%

Financials

2026 *2027 *
Net sales 50.29B 44.23B 41.09B 37.79B 70.87B 4,870B 72.14B 491B 192B 2,375B 189B 185B 8,241B 54.63B 48.05B 44.63B 41.05B 76.99B 5,290B 78.37B 534B 208B 2,580B 205B 201B 8,952B
Net income 6.32B 5.56B 5.16B 4.75B 8.91B 612B 9.07B 61.74B 24.08B 299B 23.72B 23.21B 1,036B 7.94B 6.99B 6.49B 5.97B 11.2B 769B 11.4B 77.62B 30.28B 375B 29.83B 29.18B 1,302B
Net Debt 23.38B 20.56B 19.1B 17.57B 32.95B 2,264B 33.54B 228B 89.1B 1,104B 87.78B 85.88B 3,832B 15.74B 13.85B 12.86B 11.83B 22.19B 1,525B 22.58B 154B 60B 744B 59.11B 57.83B 2,580B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
23/07/26 US$100.75 +0.18% 9,949,367
22/07/26 US$100.57 +0.90% 10,257,524
21/07/26 US$99.67 -1.96% 11,656,451
20/07/26 US$101.66 +0.97% 14,390,641
17/07/26 US$100.68 +1.87% 19,913,777
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
100.75USD
Average target price
119.12USD
Spread / Average Target
+18.24%

Quarterly revenue - Rate of surprise